EM523L, a nonpeptide motilin agonist, stimulates gastric empyting and pancreatic polypeptide secretion

Peptides

Volumn 17, Issue 6, 1996, Pages 895-900

  Okano, Hiroyuki ^a   Inui, Akio ^a   Ueno, Naohiko ^a   Morimoto, Shinsuke ^a   Ohmoto, Akiyoshi ^a   Miyamoto, Masaki ^a   Aoyama, Nobuo ^a   Nakajima, Yoshito ^b   Baba, Shigeaki ^c   Kasuga, Masato ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Otsuka Assay Laboratories   (Japan)

^c Hyogo Institute of Clinical Research   (Japan)

Author keywords

blood glucose; diabetic neuropathy; insulin; motilide; vagal cholinergic mechanisms

Indexed keywords

8,9 ANHYDRO N ETHYLNORERYTHROMYCIN A 6,9 HEMIACETAL; ERYTHROMYCIN DERIVATIVE; MACROLIDE;

ADULT; AGED; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPATHY; PRIORITY JOURNAL; STOMACH EMPTYING; VAGUS NERVE;

EID: 0029855482     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00143-X     Document Type: Article

References (38)

1. 1. Adrian, T. E.; Bloom, S. R.; Besterman, H. S.; Barnes, A. J.; Cooke, T. J. C.; Russell, R. C. G.; Faber, R. G. Mechanism of pancreatic polypeptide release in man. Lancet 22:161-163; 1977.
2. 2. Bruley des Varannes, S.; Parys, V.; Ropert, A.; Chayvialle, J. A.; Rozé, C.; Galmiche, J. P. Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 109:32-39; 1995.
3. 3. Buysschaert, M.; Donckier, J.; Dive, A.; Ketelslegers, J. M.; Lambert, A. E. Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomie neuropathy. Diabetes 34:1181-1186; 1985.
4. 4. Floyd, J. C., Jr. Pancreatic polypeptide. Clin. Gastroenterol. 9:657-678; 1980.
5. 5. Fraser, R.; Horowitz, M.; Maddox, A.; Chatterton, B.; Harding, P.; Dent, J. Hyperglycemia slows gastric emptying in type I (insulin-dependent) diabetes mellitus. Diabetologia 33:675-680; 1990.
6. 6. Hashimura, E.; Shimizu, F.; Nishino, T.; Imagawa, K.; Tateishi, K.; Hamaoka, T. Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response. J. Immunol. Methods 55:375-387; 1982.
7. 7. Hossdorf, T.; Wagner, M.; Hoppe, H. W. Pancreatic polypeptide (PP) response to food in type I diabetics with and without diabetic autonomic neuropathy. Hepatogastroenterology 35:238-241; 1988.
8. 8. Inui, A.; Mizuno, N.; Ogawa, T.; Ishida, M.; Baba, S. The effects of the physical state of food on postprandial pancreatic polypeptide release in canine. Biomed. Res. Suppl. 4:245-250; 1983.
9. 9. Inui, A.; Mizuno, N.; Oya, M.; Suenaga, K.; Morioka, H.; Ogawa, T.; Ishida, M.; Baba, S. Cross-reactivities of neuropeptide Y and peptide YY with pancreatic polypeptide antisera: Evidence for the existence of pancreatic polypeptide in the brain. Brain Res. 330:386-389; 1985.
10. 10. Inui, A.; Okita, M.; Miura, M.; Hirosue, Y.; Mizuno, N.; Baba, S.; Kasuga, M. Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypoglycemia and physical exercise. Endocrinology 132:1235-1239; 1993.
11. 11. Itoh, Z.; Nakaya, M.; Suzuki, T.; Arai, H.; Wakabayashi, K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am. J. Physiol. 247:G688-694; 1984.
12. 12. Itoh, H.; Yoneda, M.; Tamori, K.; Miyamoto, Y.; Morikawa, A.; Eto, M.; Makino, I. Rapid gastric emptying and pathological changes of vagus nerve in the spontaneously diabetic Chinese hamsters. Diabetes Res. Clin. Prac. 28:89-95; 1995.
13. 13. Iwai, K.; Fukuoka, S.; Fushiki, T.; Kodaira, T.; Ikei, N. Elevation of plasma CCK concentrations after intestinal administration of a pancreatic enzyme secretion-stimulating peptide purified from rat bile-pancreatic juice: analysis with N-terminal region specific radioimmunoassay. Biochem. Biophys. Res. Commun. 136:701-706; 1986.
14. 14. Janssens, J.; Peeters, T. L.; Vantrappen, G.; Tack, J.; Urbain, J. L.; De Roo, M.; Muls, E.; Bouillon, R. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N. Engl. J. Med. 322:1028-1031; 1990.
15. 15. Jebbink, M. C. W.; Masclee, A. A. M.; van der Kleij, F. G. H.; Schipper, J.; Rovati, L. C.; Jansen, J. B. M. J.; Lamers, C. B. H. W. Effect of loxiglumide and atropine on erythromycin induced reduction in gallbladder volume in human subjects. Hepatology 16:937-942; 1992.
16. 16. Kennedy, F. P.; Go, V. L. W.; Cryer, P. E.; Bolli, G. B.; Gerich, J. E. Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomie neuropathy. Ann. Int. Med. 108:54-58; 1988.
17. 125l-motilin to duodenal muscle. Biochem. Biophys. Res. Commun. 150:877-882; 1988.
18. 18. Krarup, T.; Schwartz, T. W.; Hilsted, J.; Madsbad, S.; Verlaege, O.; Sestoft, L. Impaired response of pancreatic polypeptide to hypoglycemia: An early sign of autonomie neuropathy in diabetics. Br. Med. J. 15:1544-1546; 1979.
19. 19. Levitt, N. S.; Vinik, A. I.; Sive, A. A.; Tonder, S.; Lund, A. Impaired pancreatic polypeptide responses to insulin induced hypoglycemia in diabetic autonomic neuropathy. J. Clin. Endocrinol. Metab. 50:445-449; 1980.
20. 20. Lugari, R.; Gnudi, A.; Dall' Argine, P.; Vattini, A.; Rignanese, G.; Dall' Aglio, B.; Melchionda, N.; Colella, P.; Luciani, A.; Toscani, S.; Zandomeneghi, R. Diabetic autonomie neuropathy and impaired human pancreatic polypeptide secretion in response to food. J. Clin. Endocrinol. Metab. 64:279-282; 1987.
21. 21. Nakamura, T.; Ishii, M.; Arai, Y.; Tandoh, Y.; Terada, A.; Takebe, K. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: A pilot study. Clin. Ther. 16:989-999; 1994.
22. 22. Nakano, I.; Funakoshi, A.; Shinozaki, H.; Miyazaki, K.; Ibayashi, H.; Tateishi, K.; Hamaoka, T. High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus. Regul. Pept. 14:229-236; 1986.
23. 23. Nishino, T.; Kodaira, T.; Shin, S.; Imagawa, K.; Shima, K.; Kumahara, Y.; Yanaihara, C.; Yanaihara, N. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment. Clin. Chem. 27:1690-1697; 1981.
24. 24. Ohtawa, M.; Mizumoto, A.; Hayashi, N.; Yanagida, K.; Itoh, Z.; Omura, S. Mechanism of gastroprokinetic effect of EM5231, an erythromycin derivative, in dogs. Gastroenterology 104:1320-1327; 1993.
25. 25. Okano, H.; Saeki, S.; Inui, A.; Kawai, Y.; Ohno, S.; Morimoto, S.; Ohmoto, A.; Nakashima, T.; Miyamoto, M.; Okita, M.; Oh, T.; Aoyama, N.; Kasuga, M. Effect of trimebutine maleate on emptying of stomach and gallbladder and release of gut peptide following a solid meal in man. Dig. Dis. Sci. 38:817-823; 1993.
26. 26. Omura, S.; Tsuzuki, M.; Sunazuka, T.; Marui, S.; Toyoda, H.; Inatomi, N.; Itoh, Z. Macrolides with gastrointestinal motor stimulating activity. J. Med. Chem. 30:1941-1943; 1987.
27. 27. Peeters, T. L. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105:1886-1899; 1993.
28. 28. Peeters, T.; Matthijs, G.; Depoortere, I.; Cachet, T.; Hoogmartens, J.; Vantrappen, G. Erythromycin is a motilin receptor agonist. Am. J. Physiol. 257:G470-474; 1989.
29. 29. Peeters, T. L.; Muls, E.; Janssens, J.; Urbain, J.-L.; Bex, M.; Van Cutsem, E.; Depoortere, I.; De Roo, M.; Vantrappen, G.; Bouillon, R. Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Gastroenterology 102:97-101; 1993.
30. 30. Satoh, M.; Sakai, T.; Sano, I.; Fujikura, K.; Koyama, H.; Ohshima, K.; Itoh, Z.; Omura, S. EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum. J. Pharmacol. Exp. Ther. 271:574-579; 1994.
31. 31. Schwartz, T. W. Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 85:1411-25; 1983.
32. 32. Shiba, Y.; Mizumoto, A.; Satoh, M.; Inui, A.; Itoh, Z.; Omura, S. Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs. Gastroenterology 110:241-250, 1996.
33. 33. Stacher, G.; Peeters, T. L.; Bergmann, H.; Wiesnagrotzki, S.; Schneider, C.; Granser-Vacariu, G. V.; Gaupmann, G.; Kugi, A. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa. Gut 34:166-172; 1993.
34. 34. Tack, J. Motilin and the enteric nervous system in the control of interdigestive and postprandial gastric motility. Acta Gastroenterol. Bel. 58:21-30; 1995.
35. 35. Taylor, I. L. Pancreatic polypeptide family: Pancreatic polypeptide, neuropeptide Y, and peptide YY. In: Rauner, B. B.; Makhlouf, G. M.; Schultz, S. G., Eds. Handbook of physiology, Sect. 6, Vol 2. Bethesda: American Physiological Society; 1989:475-543.
36. 36. Whitcomb, D. C.; Taylor, I. L. A new twist in the brain-gut axis. Am. J. Med. Sci. 304:334-338; 1992.
37. 37. Witteman, B. J. M.; Edwards-Teunissen, K.; Hopman, W. P. M.; Jansen, J. B. M. J. Effect of erythromycin on pancreatic polypeptide release: Role of the vagal nerve. Neuroendocrinology 60:452-456; 1994.
38. 38. Yamashita, K.; Motohashi, M.; Yashiki, T. Sensitive high performance liquid chromatographic determination of EM523, a new erythromycin derivative in human plasma and urine with ultraviolet detection using column switching. J. Chromatogr. 616:144-150; 1993.